Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Aetna covers AI-powered coronary plaque assessments, joining other major insurers
This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider.
Stereotaxis gains FDA approval for new robotically navigated cardiac ablation catheter
This new-look RF ablation catheter moves through the use of computer-controlled magnets, providing electrophysiologists with improved maneuverability and precision.
FDA approves new stent for deep venous disease
According to Gore, the newly approved device was built with conformability, strength and fracture resistance in mind.
Cardiology pioneer Thomas Fogarty dies as 91
Fogarty created many inventions that fundamentally changed cardiac surgical practice. He also received the Presidential Medal of Technology and Innovation from President Barack Obama in 2014.
TAVR remains a viable treatment strategy for cancer patients
Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

Recent fraud cases suggest ‘fake nursing’ has become a troubling career path

A new report reveals that states are keeping databases on “imposter nurses” to slow what could be a growing trend of unlicensed individuals holding nursing positions at hospitals nationwide.

chatgpt artificial intelligence healthcare

Healthcare AI today: Bad diet advice from LLMs, ‘Dawn’ working on cancer vaccine, Generative AI earns $50M, OpenAI’s healthcare push

OpenAI, the developer of ChatGPT, has made a couple of big hires as it prepares for a major expansion into healthcare.

Edwards Lifesciences gains CE mark approval for Evoque transcatheter tricuspid valve replacement (TTVR) system

Old age, RBBB help predict when TTVR patients may require a permanent pacemaker

Though just a small, single-facility study, these findings help care teams know what to look for when performing transcatheter tricuspid valve replacement.

Prompt engineering experts' brains are wired differently

The brains of expert AI prompt engineers really are wired differently

Mastering the art of effective prompts has become a coveted skill in the fast-growing field of AI.

Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.

Medtronic receives updated FDA approval for redo TAVR

The company also launched a new clinical trial designed to follow redo TAVR patients who present with symptomatic bioprosthetic valve failure for up to five years.

First in-human trial testing 4D mammography is officially underway

Experts have suggested the emerging technology could be a “pivotal” tool for the future of breast cancer detection.

CRF unveils late-breaking clinical trials for TCT 2025 in San Francisco

This year marks the 37th annual gathering of the popular Transcatheter Cardiovascular Therapeutics conference. What started as a small gathering in 1988 has grown into one of interventional cardiology’s biggest events.

An attendee at AHA 2024 looking at educational displays on Lp(a) in the Novartis booth. Photo By Dave Fornell

Health systems use AI to target patients who may have elevated Lp(a) levels

"We can start helping people right now, and it would be meaningful if we can raise more awareness to reduce the burden of CVD," explained Katherine Wilemon, founder and CEO of the Family Heart Foundation.

Clinical

Aetna covers AI-powered coronary plaque assessments, joining other major insurers

Stereotaxis gains FDA approval for new robotically navigated cardiac ablation catheter

FDA approves new stent for deep venous disease

Cardiology pioneer Thomas Fogarty dies as 91

TAVR remains a viable treatment strategy for cancer patients